- Global trade tensions are rising amid the Trump administration’s imposition of steel, aluminum, and Section 301 tariffs
- Still, country exemptions suggest the administration is using trade steps as a negotiation tool rather than first strike in a trade war
- Section 301 investigation into China’s use of intellectual property concluded that China engaged in unfair trade practices resulting in USD 50 to USD 60 billion in tariffs on Chinese imports
- The Trump administration is particularly focused on China given the country makes up nearly 50% of the US trade deficit and is viewed as a strategic competitor. It will not go unnoticed by President Trump that the US-China trade deficit has widened since he took office.
China makes up nearly half of the US trade deficit
(As at Q1 2018)
US trade deficit with China has widened since Trump took office
- While these tariffs are likely to be used as a leverage tool in further trade negotiations with China, they also pose a risk of retaliation
- While not our base case, a full blown trade war would pose meaningful downside for global equities, particularly emerging markets
- We maintain exposure to US Treasuries and non-USD reserve currencies to hedge against an escalation in trade tensions
The bottom line: Asset allocation
At this point we view incentives within the administration as sufficiently aligned to avoid a major trade confrontation. We thus remain overweight equities given the still constructive macro backdrop and gradual removal of accommodation from central banks. That said, we maintain exposure to US duration in the event of a flight to quality due to trade. In currencies we have a bias to be underweight the dollar versus reserve currencies like the JPY and EUR, which provide a hedge against disruptive developments on the trade front.
The bottom line: Chinese equities and fixed income
While the Section 301 tariffs announced by the US increase the level of uncertainty, it’s worth noting that even if they are executed in full, we estimate the impact on China’s GDP to be just 0.1% - 0.2%. And this figure can be mitigated by further diversification of exports to other countries. Our view is that despite the negative headlines, there are clear signs that both sides have left room for negotiation and compromise. We believe that both the US and China are fundamentally pro trade and keen to avoid a major escalation.
Within China equity portfolios some of our stocks do have a small component of revenue exposure to the US. But overall, these portfolios are predominantly exposed to the theme of China’s economic rebalancing from ‘old economy’ manufacturing toward ‘new economy’ consumption and services. With a focus on the domestic economy rather than exporters we believe we are well positioned to ride out this volatility with key holdings in healthcare, consumers and internet/ecommerce.
Within China fixed income portfolios, our view is that these tensions will ultimately amount to very little. There are some clear lessons from the past. In the 1980s, the US threatened Japan with wide-ranging tariffs to address deficits, open up Japanese markets, and protect US firms’ intellectual property. While various special commissions investigated trade malpractices, what happened then largely boiled down to political noise. We see a similar scenario this time round.
Of much greater significance is the announcement today that RMB-denominated Chinese bonds are to be phased in to the key Barclays Bloomberg Global Aggregate Index over a 20-month period starting April 2019.
THIS WEBSITE IS NOT INTENDED FOR AND SHOULD NOT BE ACCESSED BY PERSONS LOCATED OR RESIDENT IN ANY JURISDICTION WHERE (BY REASON OF THAT PERSON'S NATIONALITY, DOMICILE, RESIDENCE OR OTHERWISE) THE PUBLICATION OR AVAILABILITY OF THIS WEBSITE IS PROHIBITED OR CONTRARY TO LOCAL LAW OR REGULATION OR WOULD SUBJECT ANY UBS ENTITY TO ANY REGISTRATION OR LICENSING REQUIREMENTS IN SUCH JURISDICTIONS. IT IS YOUR RESPONSIBILITY TO BE AWARE OF, TO OBTAIN ALL RELEVANT REGULATORY APPROVALS, LICENCES, VERIFICATIONS AND/OR REGISTRATIONS UNDER, AND TO OBSERVE ALL APPLICABLE LAWS AND REGULATIONS OF ANY RELEVANT JURISDICTION IN CONNECTION WITH YOUR ENTRANCE TO THIS WEBSITE. EACH INVESTMENT PRODUCT AND SERVICE REFERRED TO ON THIS WEBSITE IS INTENDED TO BE MADE AVAILABLE ONLY TO RESIDENTS IN SINGAPORE.
UBS RESERVES THE RIGHT TO CHANGE, MODIFY, ADD OR REMOVE CONTENT ON THE WEBSITE AS WELL AS THESE TERMS AT ANY TIME FOR ANY REASON WITHOUT NOTICE. SUCH CHANGES SHALL BE EFFECTIVE IMMEDIATELY UPON POSTING. YOU ACKNOWLEDGE THAT BY ACCESSING OUR WEBSITE AFTER WE HAVE POSTED CHANGES TO THESE TERMS, YOU ARE AGREEING TO THESE TERMS AS MODIFIED.